Problem

Entrepreneurs are recognized as idea engineers. They are inventors of innovative change who bring forth a product or technology that has the prospect of making a measurable impact to a particular society. However, the stats have continually indicated that only a small margin of start-ups reap the reward of successful commercialization. Many entrepreneurs fall into the geek-in-the garage paradox, ideas are left behind in university labs and the prospect of success diminishes. Larry Laskey, who is a Ph.D partner at US venture Partners mentioned that scientists often get caught up in their excitement over the science, and they forget that the VC is focused on the business. This complex is prevalent across any industry. Entrepreneurs invest their time, personal savings and wealth on the notion that their product will be a profitable success. In context to synthetic biology, the level of novelty & complexity of the industry also places a challenge for synbio entrepreneurs. For years, there has been a considerable level of focus on the scientific feasibility of a technology versus its viability from a commercialization standpoint. Synthetic biologists have aimed to build and strengthen their knowledge of the tools and techniques required to create these optimal genetic machines and may not have the time or residual money to invest in services that would help to enhance their entrepreneurial mindset. However, there is an interest for synthetic biologists to learn more about entrepreneurship and independently launch a start-up. Given the newness of the field, tailored education and inexpensive consulting offerings in specificity to synthetic biology & biotechnology is limited.